Menu Search
Equities

Daiichi Sankyo Co Ltd

4568:TYO

Daiichi Sankyo Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)4,483.00
  • Today's Change-19.00 / -0.42%
  • Shares traded4.60m
  • 1 Year change+11.94%
  • Beta1.2561
Data delayed at least 20 minutes, as of Nov 21 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy6
Outperform10
Hold1
Sell0
Strong Sell0

Share price forecast in JPY

The 15 analysts offering 12 month price targets for Daiichi Sankyo Co Ltd have a median target of 6,350.00, with a high estimate of 7,600.00 and a low estimate of 5,600.00. The median estimate represents a 41.65% increase from the last price of 4,483.00.
High69.5%7,600.00
Med41.6%6,350.00
Low24.9%5,600.00

Dividends in JPY

In 2024, Daiichi Sankyo Co Ltd reported a dividend of 50.00 JPY, which represents a 66.67% increase over last year. The 14 analysts covering the company expect dividends of 63.33 JPY for the upcoming fiscal year, an increase of 26.67%.
Div growth (TTM)66.67%
More ▼

Earnings history & estimates in JPY

On Oct 31, 2024, Daiichi Sankyo Co Ltd reported 2nd quarter 2025 earnings of 32.23 per share. This result exceeded the 26.40 consensus of the 4 analysts covering the company and exceeded last year's 2nd quarter results by 54.58%.
The next earnings announcement is expected on Jan 28, 2025.
Average growth rate+31.18%
Daiichi Sankyo Co Ltd reported annual 2024 earnings of 104.69 per share on Apr 25, 2024.
Average growth rate+23.75%
More ▼

Revenue history & estimates in JPY

Daiichi Sankyo Company, Limited had 2nd quarter 2025 revenues of 446.55m. This bettered the 435.80m consensus of the 6 analysts covering the company. This was 27.28% above the prior year's 2nd quarter results.
Average growth rate+4.77%
Daiichi Sankyo Company, Limited had revenues for the full year 2024 of 1.60bn. This was 25.28% above the prior year's results.
Average growth rate+13.56%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.